Pleva L, et al. - Researchers compared long-term outcomes following paclitaxel-eluting balloon catheters (PEB) vs everolimus-eluting stents (EES) for the treatment of bare-metal stent restenosis (BMS-ISR), using 3-year clinical follow-up data from patients included in the TIS randomized clinical study. Either PEB or EES (68 patients with 74 ISR lesions per group) was used to treat a total of 136 patients with BMS-ISR. Findings of a 3-year follow-up demonstrated that use of iopromide-coated PEB vs EES for the treatment of BMS-ISR did not yield significantly different clinical outcomes.